Most Recent

image: Subway Microbiome

Subway Microbiome

By | February 9, 2015

Researchers document the bacterial life living among New York City’s transit stations.

0 Comments

image: Long-Lived Immunotherapy Stem Cells

Long-Lived Immunotherapy Stem Cells

By | February 4, 2015

Genetically modified T memory stem cells persist in patients for more than 10 years, and can differentiate into a variety of T cell types.

1 Comment

image: Methylation Predicts Mortality

Methylation Predicts Mortality

By | February 3, 2015

A study finds a link between patterns of methylation in the human genome and people’s life span.

0 Comments

image: B Cell Bosses

B Cell Bosses

By | February 1, 2015

Gut bacteria in mice spur regulatory B cells to differentiate and release an anti-inflammatory cytokine.

0 Comments

image: Centennial <em>Shigella</em>

Centennial Shigella

By | February 1, 2015

A strain of the dysentery-causing bacterium isolated in 1915 tells the story of a young soldier who died of the disease in the early days of World War I.

0 Comments

image: Nibbled? No Problem

Nibbled? No Problem

By | February 1, 2015

Making extra copies of their genomes allows some plants to better withstand damage.

0 Comments

image: Pushing the Limits

Pushing the Limits

By | February 1, 2015

A guide to the newest techniques for examining epigenetics in single cells

0 Comments

image: Screening Goes In Silico

Screening Goes In Silico

By | February 1, 2015

Computational tools take some of the cost—and guesswork—out of drug discovery.

0 Comments

image: Stubbornly Persistent

Stubbornly Persistent

By | February 1, 2015

Microorganisms continually challenge our assumptions of what life can achieve.

1 Comment

image: Thanks for the Memories

Thanks for the Memories

By | February 1, 2015

B and T cells may be the memory masters of the immune system, but research reveals that other cells can be primed by pathogens, too.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech